|
|
 |
|
|
Current Directors |
Past Directors
Chair
Dr. Bruce P. Clayman is a member of Simon Fraser University's Centre for Policy Research on Science and Technology. He served as President of the Great Northern Way Campus from September 2004 to December 2006. Dr. Clayman was a founding member of the federal Interagency Advisory Panel on Research Ethics and served as its chair from 2005-2007. He served as Vice President, Research at SFU for 11 years ending in 2004 and Dean of Graduate Studies from 1985 to 2000. A physics Professor at SFU, his research interests have evolved to include technology transfer and the commercialization productivity of universities. Dr. Clayman is a member of the Board of the non-profit Discovery Parks Trust that operates Discovery Parks Inc., a for-profit company that develops and manages research and development real estate projects. His interest in economic development has led to his membership on the Vancouver Economic Development Commission.
|
|
Interim Co-Vice Chair
Bill Barrable was appointed Chief Executive Officer of British
Columbia Transplant in January 1994. He continues to head
transplant services for British Columbia, now as Provincial Director. Under his leadership, BC Transplant was
awarded the Canada Award for Excellence from the National Quality
Institute in 2000. In 2001, he became the founding Chair of the Board of Directors of the Michael Smith Foundation
for Health Research. He is also a member of the Board of Directors of the Western Healthcare Improvement Network (WHIN).
Mr. Barrable holds a Bachelor of Arts (Honours)
from Queen’s University, and a Master of Health Science in
Healthcare Administration from the University of Toronto.
|
|
Natalie Dakers is Chief Executive Officer of the Centre for Drug Research and Development. Ms. Dakers was President & CEO of Neuromed Technologies Inc., a private biopharmaceutical company developing drugs for chronic pain, anxiety, epilepsy and cardiovascular diseases. As co-founder, she built the company from inception and raised three rounds of venture financing totaling approximately $70 million. Under her leadership, the company filed its first Investigational New Drug (IND) application for a novel chronic pain drug and commenced Phase 1 clinical trials. Prior to co-founding Neuromed, Ms. Dakers was a Senior Manager for life sciences technology transfer at the University Industry Liaison Office (UILO) at the University of British Columbia. In this capacity, she was involved in the creation and spin-off of more than a dozen start-up high-tech and biotech companies. Ms. Dakers served as Chair of BC Biotech, the association representing and promoting the province's biotech firms. From 1999 to 2001, she served as a board member of AceTech Academy of Technology CEOs. Ms. Dakers has also served as Vice-President of the Association of University Technology Managers and as Director of the Premier's Advisory Council of Science and Technology.
|
|
Bob de Faye was appointed Chief Administrative Officer of the BC Ministry of Health in January 2007. Prior to joining the Ministry of Health he was the Chief Executive Officer of the Public Sector Employers' Council Secretariat. Mr. de Faye has held a wide variety of senior and executive positions during his 28 year public service career, including Deputy Minister of the Ministry of Community, Aboriginal and Women's Services; Assistant Deputy Minister for the Provincial Treasury; A/Assistant Deputy Minister for the Crown Corporations Secretariat; Assistant Deputy Minister for Government Services; Chief Executive Officer of the Purchasing Commission; Senior Policy Director with Cabinet Planning Secretariat; and Director of Policy for the Ministry of Health.
|
|
Dr. David Dolphin is Vice-President, Technology Development at QLT Inc., and a Professor of Chemistry and the QLT/NSERC Industrial Research Professor in Photodynamic Technologies at the University of British Columbia. Also at UBC, Dr. Dolphin was Acting Vice President Research (1999-2000) and Acting Dean of Science (1988-1989). Dr. Dolphin is an internationally recognized expert in porphyrin chemistry and biochemistry and has been instrumental in the development of drugs for photodynamic therapy. He is the author and editor of 18 books on spectroscopy, chemistry and biochemistry and has published over 400 research papers and holds numerous patents. Dr. Dolphin is a Fellow of the Canadian Institute of Chemistry, Royal Society of Chemistry, Royal Society of Canada and Royal Society (London). In 2002, he received the Prix Galien Award and Friesen Rygiel Prize. In 2003 he received the CSPS Award of Leadership in Canadian Pharmaceutical Sciences, was nominated the CUFA/BC Academic of the Year and was nominated a University Killam Professor. In 2004 he was designated a Hero of Chemistry by the American Chemical Society and received an NSERC Award of Excellence.
|
|
Interim Co-Vice Chair
Alistair Duncan is President and CEO of Vancouver-based biotechnology company viDA Therapeutics Inc. From 1998 to 2008 Mr. Duncan was President and CEO of Chromos Molecular Systems Inc., where he was also a founder and Director.
Prior to that, he was a Principal with the
Ernst & Young Corporate Finance and International Life Sciences
Group where he provided high technology and life sciences companies
with corporate advisory services in strategic planning, valuations,
financing, divestitures, and mergers & acquisitions. Mr. Duncan
holds a CA designation and a BSc in Biochemistry from the University
of British Columbia.
|
|
Dr. Judith Hall is a clinical geneticist and pediatrician who trained at
Wellesley College, the University of Washington School of Medicine
and Johns Hopkins Hospital. She is Professor Emeritus of Pediatrics
and Medical Genetics at the University of British Columbia based
at Children's & Women's Health Centre of British Columbia. She was
Head of Pediatrics at UBC and BC's Children's Hospital from 1990
to 2000. Her research is focused on human congenital anomalies,
including neural tube defects, the genetics of short stature and
dwarfism. Among many honours and awards, Dr. Hall was made an Officer
of the Order of Canada in 1998 in recognition of her leadership
in the advancement of child health through clinical, teaching and
research excellence.
|
|
Sue Paish was appointed Chief Executive Officer of Pharmasave Drugs (National) Limited in 2007. Prior to taking the CEO position, Ms. Paish served for six years as the Managing Partner of Fasken Martineau Dumoulin, a Vancouver-based international law firm. She has more than 24 years of law experience. Ms. Paish has been a Director for various corporate and community boards, including ICBC, Vancouver Board of Trade, BC Women's Hospital Foundation and the Pharmasave National Board. In 2005, the Women's Executive Network named her to the list of Canada's Most Powerful Women: Top 100. In 2004, she received a Business in Vancouver Influential Women in Business Award. In 2003, Ms. Paish was named one of Canada's Top 25 Women Lawyers. She lectures to and has written extensively for various business and legal organizations.
|
|
Dr. Moura Quayle was appointed Deputy Minister of Advanced Education for the Government of British Columbia in June 2005. She was previously Dean of the Faculty of Land and Food Systems (formerly Agricultural Sciences) at the University of British Columbia, Director of the UBC Landscape Architecture Program, and Associate Vice-President of UBC's Okanagan Programs. Dr. Quayle is a Fellow of the Canadian Society of Landscape Architects and a member of Environment Canada's National Science and Technology Advisory Board . She chaired the 2004 Science and Technology Management Review Panel of Environment Canada, and the City of Vancouver's Urban Landscape Task Force. Dr. Quayle was named a 1993 YWCA Woman of Distinction for communication and public affairs. In 2004, she received a Doctor of Science, honoris causa, in recognition of her outstanding academic leadership, contributions to the professional community of landscape architecture and her work on agricultural issues in contemporary society.
|
|
Brent Sauder was appointed Assistant Deputy Minister, Research, Technology and Innovation, in the BC Ministry of Advanced Education in 2007. Mr. Sauder has more than 20 years experience in the research sector. From 2002 to 2007 he served as Director, Office of Research Services at the University of British Columbia, responsible for the management of research funding and ethics compliance. Prior to that he held positions at the BC Advanced Systems Institute, MacMillan Bloedel and the Forest Engineering Research Institute of Canada. Mr. Sauder has served as a member of the Science Council of British Columbia, and a director of various non and for-profit organizations.
|
|
Dr. S. Martin Taylor is the founding President and CEO of Ocean Networks Canada, a not-for-profit organization created by the University of Victoria to manage the VENUS and NEPTUNE Canada ocean observatories. Dr. Taylor was UVic's Vice-President, Research from 1998 to 2007. From 1974 to 1998, Dr. Taylor was a Professor in the Department of Geography at McMaster University. During that time, he served as Chair of Geography (1991-97), founding Director of the Institute of Environment and Health (1991-96), and as Acting Vice President, Research (1994-95). Dr. Taylor's research and teaching interests focus on environmental health and health promotion. Current and recent projects include the psychosocial effects of environmental contamination, community-based heart health promotion, and the impacts of economic restructuring on population health in coastal communities in BC. He has authored one book and over 100 papers in peer-reviewed journals. Dr. Taylor is a co-Investigator in the Coasts under Stress project, funded by SSHRC and NSERC, with particular focus on the effects of socio-economic restructuring on population, community and personal health in BC coastal communities. In 2008 he received LifeSciences British Columbia's Leadership Award.
|
|
Secretary–Treasurer
Dr. Paul Terry is a partner in Magellan Angel Partners, a high-tech angel fund. Dr. Terry was formerly the CTO of Cray Canada, and CTO, VP Engineering of Redback Canada. He was one of the co-founders of OctigaBay Systems (acquired by Cray) and Abatis Systems (acquired by Redback). Dr. Terry holds a Class I degree in Physics and Electronics, a PhD in Electronics and Electrical Engineering from the University of Liverpool in England, and an MBA from Cranfield University. Dr Terry's interests and activities include networking, nanotech and supercomputing.
|
|
Cathy Ulrich was appointed President and Chief Executive Officer of Northern Health in June 2007. Ms. Ulrich was Northern Health's Vice-President of Clinical Services and Chief Nursing Officer from 2002 to 2007. She has a wide range of experience and strong academic background. Ms. Ulrich has spent the majority of her career in rural and northern locations, where she gained a solid understanding of the nature of rural and northern communities, their health needs and concerns, and the unique approaches required to meet these needs. She has also been actively engaged in health services research, teaching and graduate student support.
Ex-officio Members
|
|
Chair, Research Advisory Council
|
|
President & CEO
Dr. John Challis was appointed President and Chief Executive Officer of the Michael Smith Foundation for Health Research in July 2008. A Fellow of the Royal Society of Canada, Dr. Challis received his undergraduate education at the University of Nottingham and PhD from the University of Cambridge. He conducted post-doctoral work at the University of California, San Diego and at Harvard Medical School before returning to the University of Oxford as a research scientist in 1974. He came to Canada in 1976 as a faculty member at McGill University and joined the faculty at the University of Western Ontario two years later. Dr. Challis served as Scientific Director of the Lawson Research Institute at St. Joseph's Health Centre and as the Centre's Vice-President (Research).
He joined the University of Toronto as Professor and Chair of the department of physiology in 1995. In 2001, he was appointed as the founding Scientific Director of the Canadian Institutes of Health Research, Institute of Human Development, Child and Youth Health. His most recent position was Vice-President, Research and Associate Provost at the University of Toronto. An internationally-recognized researcher in the fields of physiology, obstetrics and gynecology, Dr. Challis’ specific areas of research interest include hormone mechanisms during pregnancy, fetal and placental endocrinology and the influence of intrauterine development on disease after birth.
|
Back to Top
|
|
|
|
Last updated October 1, 2008
|
|
|
